Literature DB >> 31097102

The novel microRNA hsa-miR-CHA1 regulates cell proliferation and apoptosis in human lung cancer by targeting XIAP.

Jung Ki Yoo1, Ji Min Lee1, Seung Hee Kang1, Seong Ho Jeon1, Chang Min Kim1, Seung-Hun Oh2, Chang-Hyun Kim3, Nam Keun Kim4, Jin Kyeoung Kim5.   

Abstract

OBJECTIVES: MicroRNAs have critical roles in cancer development by regulating the expression of oncogenes or tumor suppressor genes. We identified and characterized a novel miRNA, miR-CHA1, in human lung cancer cells. The aim of this study was to investigate its novel function in human lung cancer by targeting XIAP.
MATERIAL AND METHODS: Novel miRNA cloning, Real-time qRT-PCR, western blotting, dual luciferase assay, miRNA transfection, proliferation and apoptosis assay were carried on human lung cancer cell line A549. Fifteen paired NSCLC tissues and noncancerous lung tissues were collected. In vivo xenograft assay was performed.
RESULTS: Expression of miR-CHA1 was downregulated in human lung cancer cell lines and tissues compared with normal cells and tissues. We identified a putative target gene, XIAP, whose expression was regulated by miR-CHA1 overexpression. XIAP is an inhibitor of apoptosis that represses the activation of caspase 3 and 9. XIAP mRNA and protein levels were directly suppressed by miR-CHA1. XIAP has an important role in carcinogenesis, and previous studies suggest that it may regulate cell survival and proliferation by its anti-apoptotic ability.
CONCLUSION: Taken together, miR-CHA1 inhibited cell proliferation and induced apoptosis in vitro and in vivo by targeting XIAP. These data can be applied to identify novel therapeutic targets for lung cancer therapy.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Cell proliferation; Lung cancer; Novel microRNA; XIAP

Mesh:

Substances:

Year:  2018        PMID: 31097102     DOI: 10.1016/j.lungcan.2018.04.011

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  5 in total

1.  MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.

Authors:  Xianhai Mao; Bingzhang Tian; Xiaohui Duan; Wei Li; Peng Hu; Bo Jiang; Jianhui Yang; Lixue Zhou
Journal:  Biosci Rep       Date:  2020-10-30       Impact factor: 3.840

Review 2.  XIAP's Profile in Human Cancer.

Authors:  Huailu Tu; Max Costa
Journal:  Biomolecules       Date:  2020-10-29

3.  Müller glia-derived exosomal miR-9-3p promotes angiogenesis by restricting sphingosine-1-phosphate receptor S1P1 in diabetic retinopathy.

Authors:  Yu Liu; Qin Yang; Haixin Fu; Jingfan Wang; Songtao Yuan; Xinsheng Li; Ping Xie; Zizhong Hu; Qinghuai Liu
Journal:  Mol Ther Nucleic Acids       Date:  2021-12-17       Impact factor: 8.886

Review 4.  Current Landscape of Epigenetics in Lung Cancer: Focus on the Mechanism and Application.

Authors:  Yuan-Xiang Shi; De-Qiao Sheng; Lin Cheng; Xin-Yu Song
Journal:  J Oncol       Date:  2019-12-12       Impact factor: 4.375

5.  miRNA-21 may serve as a promising noninvasive marker of glioma with a high diagnostic performance: a pooled analysis of 997 patients.

Authors:  Xinli Zhao; Zhihong Xiao; Bin Li; Hongwei Li; Bo Yang; Tian Li; Zubing Mei
Journal:  Ther Adv Med Oncol       Date:  2021-01-31       Impact factor: 8.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.